Press Release

GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET PROJECTED TO GROW AT A CAGR OF 4.82% FROM 2019 TO 2024 – AXIOM MRC

July, 2018: Axiom Market Research & Consulting™ added a report on global clinical chemistry analyzers market. The global clinical chemistry analyzers market was valued at USD 10.77 billion in 2017, growing at a CAGR of 4.82% for the forecast period 2019 to 2024. The global market is estimated and forecasted in terms of revenue (USD billion) generated by the clinical chemistry analyzers market.

The global clinical chemistry analyzers market is segmented based on type, test, end user and geography. The major types of clinical chemistry analyzers market are semi-automated and automated devices, further divided into entry level, medium throughput analyzers, high throughput analyzers, and high throughput modular analyzers along with reagents which include metabolites, enzymes, Electrolytes and others which include proteins, lipoprotein, other reagents and consumables. By test type, the clinical chemistry analyzers market is segmented such as, basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile, thyroid function panel and specialty chemicals. The clinical chemistry analyzers are mainly used in hospitals, commercial laboratories, academic institutions, and are used by blood banks, cancer research centers among others. The global clinical chemistry analyzers market is studied for North America, Europe, Asia-Pacific, and RoW that includes the Middle East & Africa and the remaining countries.

Hospitals is the largest end user of clinical chemistry analyzers globally and it will remain largest segment by 2024 also. Hospitals are challenged by POC devices segment and commercial laboratories with their ease of testing and cost effective testing services respectively. Physicians services at the hospitals, large number of facilities, and well equipped laboratories are the strategies opted by hospitals to provide testing services as low as private labs

The global clinical chemistry analyzers market is driven by factors such as increasing healthcare expenditure, ageing population in North America and Europe and growing trend of automation of laboratories to lower the cost and time of tests.

The leading players of the global clinical chemistry analyzers market are Abbott Laboratories, Becker Coulter (Danaher Corporation), Johnson & Johnson, Ortho-Clinical Diagnostics, Inc., F. Hoffmann-La Roche, Siemens AG, Thermo Fisher Scientific Inc., Horiba Ltd, Elitech Group, Randox Laboratories Ltd and Mindray Medical International Limited among others.

Media Contact:

Ganesh Sai
616 Corporate Way, Suite 2-4268
Valley Cottage, NY, United States
Email: sales@axiommrc.com
Tel: +1(845)875-9786, +44(0) 20 23869707

FAQ | Terms & Conditions | Disclaimer | Blog | Privacy Policy | Our Client | Contact Us

Copyright ©2018 Axiom Market Research & Consulting™ and its Affiliates